Altimmune Inc. (ALT)
undefined
undefined%
At close: undefined
8.99
0.06%
After-hours Dec 13, 2024, 06:44 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05
Revenue 426.00K -68.00K 4.41M 8.19M 5.80M 10.33M 41.50K 5.23M 10.64M 10.19M 17.91M 25.18M 24.27M 20.99M 27.55M 32.91M 14.64M 1.85M 586.07K
Cost of Revenue 477.00K 68.00K 551.30K 33.51M 17.07M 18.46M 18.41M 7.22M 5.06M 4.27M - - - - - - - - 115.00K
Gross Profit -51.00K -136.00K 3.86M -25.32M -11.26M -8.13M -18.36M -1.99M 5.58M 5.93M 17.91M 25.18M 24.27M 20.99M 27.55M 32.91M 14.64M 1.85M 471.07K
Operating Income -95.93M -87.74M -96.91M -54.80M -21.46M -42.83M -52.05M -11.26M -3.40M -10.19M -10.84M -6.27M -11.73M -23.55M -25.97M -35.24M -16.50M 1.20M 325.30K
Interest Income 7.35M 2.87M 202.74K 322.51K 843.41K 226.60K 47.58K 1.05K - 695.00M 2.58K 17.81K 16.66K 6.96K 269.13K 1.23M 1.12M 1.85M 586.07K
Pretax Income -88.45M -84.91M -97.09M -54.46M -20.58M -45.32M -52.06M 205.02M -3.38M -9.89M -11.66M -4.72M -3,797.60B -34,849.30B -32.28B -36.42B -13.59M 1.20M 325.30K
Net Income -88.45M -84.71M -96.17M -49.04M -20.52M -39.17M -46.43M 193.85M -3.44M -9.96M -11.72M -4.92M -3.80M -34.85M -32.28M -36.42M -13.59M 1.02M 277.30K
Selling & General & Admin 18.14M 17.13M 15.41M 13.21M 8.50M 9.77M 8.46M 11.52M 6.22M 10.91M 13.28M 11.63M 14.31M 18.02M 22.43M 19.40M 13.88M 491.09K 145.78K
Research & Development 65.80M 70.54M 74.54M 49.77M 17.77M 18.46M 18.41M 4.84M 5.13M 9.32M 15.29M 19.51M 21.22M 20.88M 30.22M 31.81M 16.56M - -
Other Expenses 12.42M -32.00K -373.87K 24.15K 15.14K 277.89K 5.67K 7.85K 8.14K -762 -6.07K 47.86K 461.07K 5.66M 872.30K 813.89K 705.37K 153.28K -
Operating Expenses 96.36M 87.67M 89.95M 62.98M 26.27M 28.22M 16.17M 16.49M 11.50M 20.38M 28.75M 31.44M 35.99M 44.55M 53.52M 52.02M 31.15M 644.38K 145.78K
Interest Expense 35.00K 8.00K 5.66K 9.42K 2.24K 297.09K 162.14K 168.15B 54.58K 210.40K 369.28K 342.56K 54.57K 5.94M 2.84M 2.57M 2.12M - -
Selling & Marketing Expenses - - - - - - - - - - - - - - - - - - -
Cost & Expenses 96.36M 87.67M 89.95M 62.98M 26.27M 28.22M 16.17M 16.49M 11.50M 20.38M 28.75M 31.44M 35.99M 44.55M 53.52M 52.02M 31.15M 644.38K 260.78K
Income Tax - -197.00K -919.51K -5.42M -58.50K -6.15M -5.64M 11.17M 61.75K 61.75K 61.75K 195.53K -7.93M 15.93M 6.31M 17.30M -2.87M 187.00K 48.00K
Shares Outstanding (Basic) 53.25M 46.93M 41.28M 25.64M 13.12M 2.80M 426.83K 230.38K 213.28K 191.78K 168.86K 161.07K 157.77K 107.70K 91.92K 76.48K 31.48K 1.89K 26.23K
Shares Outstanding (Diluted) 53.25M 46.93M 41.28M 25.64M 13.12M 2.80M 426.83K 230.38K 213.28K 191.78K 168.86K 161.07K 157.77K 107.70K 91.92K 76.48K 31.48K 1.89K 27.74K
EPS (Basic) -1.66 -1.81 -2.33 -1.91 -1.56 -13.98 -108.77 -49.8 -16.13 -51.91 -69.4 -30.55 -24.07 -323.59 -351.19 -476.15 -431.69 -11.48K 12.00
EPS (Diluted) -1.66 -1.81 -2.33 -1.91 -1.56 -13.98 -108.77 -49.8 -16.13 -51.91 -69.4 -30.55 -24.07 -323.59 -351.19 -476.15 -431.69 -11.48K 9.00
EBITDA -87.94M -84.40M -96.53M -54.15M -20.19M -44.72M -51.76M -10.91M -3.18M -9.53M -11.10M -4.08M -3.28M -23.26M -28.57M -33.03M -15.80M -14.05M 325.30K
Depreciation & Amortization 477.00K 500.00K 551.30K 298.06K 387.32K 302.37K 139.02K 135.34K 141.60K 149.96K 182.49K 303.92K 461.07K 1.02M 872.30K 813.89K 655.21K - -